Voya Investment Management LLC Intra Cellular Therapies, Inc. Transaction History

Voya Investment Management LLC

$79.9 Billion
Q3 2024

A detailed history of Voya Investment Management LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 74,967 shares of ITCI stock, worth $6.48 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

74,967

Previous 78,053 3.95%

Holding current value

$6.48 Million

Previous $5.35 Million 2.54%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$67.99 - $80.84 $209,817 - $249,472	-3,086 Reduced 3.95%	74,967 $5.48 Million
Q2 2024 Aug 14, 2024	SELL	$64.76 - $79.84 $5.51 Million - $6.79 Million	-85,096 Reduced 52.16%	78,053 $5.35 Million
Q1 2024 May 15, 2024	BUY	$64.37 - $75.65 $142,450 - $167,413	2,213 Added 1.38%	163,149 $11.3 Million
Q4 2023 Feb 14, 2024	BUY	$46.37 - $73.65 $667,217 - $1.06 Million	14,389 Added 9.82%	160,936 $11.5 Million
Q3 2023 Nov 14, 2023	BUY	$52.09 - $64.1 $42,349 - $52,113	813 Added 0.56%	146,547 $7.63 Million
Q2 2023 Aug 14, 2023	BUY	$54.67 - $66.44 $516,467 - $627,658	9,447 Added 6.93%	145,734 $9.23 Million
Q1 2023 May 15, 2023	SELL	$43.8 - $56.99 $1,007 - $1,310	-23 Reduced 0.02%	136,287 $7.38 Million
Q4 2022 Feb 14, 2023	BUY	$44.07 - $54.45 $53,236 - $65,775	1,208 Added 0.89%	136,310 $7.21 Million
Q3 2022 Mar 03, 2023	SELL	$42.7 - $59.99 $51,581 - $72,467	-1,208 Reduced 0.89%	135,102 $6.29 Million
Q3 2022 Nov 14, 2022	BUY	$42.7 - $59.99 $559,028 - $785,389	13,092 Added 10.73%	135,102 $6.29 Million
Q2 2022 Aug 15, 2022	BUY	$43.0 - $65.64 $697,804 - $1.07 Million	16,228 Added 15.34%	122,010 $6.97 Million
Q1 2022 May 16, 2022	BUY	$38.74 - $62.09 $3.02 Million - $4.84 Million	77,963 Added 280.25%	105,782 $6.47 Million
Q4 2021 Feb 14, 2022	BUY	$35.2 - $53.42 $457 - $694	13 Added 0.05%	27,819 $1.46 Million
Q2 2021 Aug 16, 2021	SELL	$29.3 - $44.5 $45,239 - $68,708	-1,544 Reduced 5.26%	27,806 $1.14 Million
Q1 2021 May 17, 2021	BUY	$30.8 - $39.51 $28,274 - $36,270	918 Added 3.23%	29,350 $996,000
Q4 2020 Feb 16, 2021	BUY	$23.34 - $32.22 $153,460 - $211,846	6,575 Added 30.08%	28,432 $904,000
Q3 2020 Nov 16, 2020	BUY	$17.61 - $31.86 $45,099 - $81,593	2,561 Added 13.27%	21,857 $561,000
Q2 2020 Aug 14, 2020	SELL	$14.35 - $26.64 $94,193 - $174,864	-6,564 Reduced 25.38%	19,296 $495,000
Q1 2020 May 15, 2020	BUY	$12.31 - $33.12 $45,830 - $123,305	3,723 Added 16.82%	25,860 $397,000
Q4 2019 Feb 14, 2020	BUY	$7.26 - $38.49 $19,304 - $102,344	2,659 Added 13.65%	22,137 $760,000
Q4 2018 Feb 14, 2019	BUY	$10.36 - $20.96 $10,681 - $21,609	1,031 Added 5.59%	19,478 $222,000
Q2 2018 Aug 14, 2018	BUY	$17.33 - $23.4 $6,602 - $8,915	381 Added 2.11%	18,447 $326,000
Q4 2017 Feb 14, 2018	BUY	$14.27 - $16.79 $16,481 - $19,392	1,155 Added 6.83%	18,066 $262,000
Q3 2017 Nov 14, 2017	BUY	$10.77 - $22.1 $182,131 - $373,733	16,911	16,911 $267,000

Others Institutions Holding ITCI

# of Institutions

378

Shares Held

84.7M

Call Options Held

319K

Put Options Held

143K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $8.16B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Intra Cellular Therapies, Inc. Transaction History